In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving ...
Jun 2, 2023
0
97
Overall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which harness the power of the immune system to attack cancer cells, have garnered excitement in recent ...
May 31, 2023
0
70
May is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer.
May 23, 2023
0
0
A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes. A specificity of 84% suggests that it may reduce the number ...
May 12, 2023
0
2
A new study led by Cláudia C. Faria, researcher in the lab of João Taborda Barata at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and neurosurgeon at the Centro Hospitalar Universitário Lisboa Norte ...
May 1, 2023
0
3
In a new study, researchers from The University of Texas MD Anderson Cancer Center have created the largest single-cell atlas of brain metastases from renal cell carcinoma (RCC) with matched primary and extracranial metastases, ...
Apr 18, 2023
0
1
For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT), and doublet therapy ...
Apr 12, 2023
0
9
In a new study from Tel Aviv University published in the journal Nature Cancer, a team of researchers led by Prof. Neta Erez, head of the laboratory for the biology of tumors from the Department of Pathology at the Sackler ...
Feb 22, 2023
0
62
In non-cirrhotic liver diseases, organ transplantation in two steps, especially with a living donation, is a safe therapy option for donors and recipients. This is the conclusion of a case series evaluated by surgeons from ...
Jan 31, 2023
0
2
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer. One of the key features involves changes in the immune system that ...
Jan 9, 2023
0
48
